Dorte Vistisen Selected Research

Dorte Vistisen Research Topics

Disease

21	Type 2 Diabetes Mellitus (MODY) 10/2023 - 09/2013
18	Insulin Resistance 01/2023 - 03/2008
12	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2023 - 08/2017
11	Prediabetic State (Prediabetes) 01/2023 - 06/2014
10	Overweight 01/2023 - 07/2015
9	Obesity 01/2023 - 10/2013
6	Glucose Intolerance 01/2022 - 04/2009
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2018
3	Body Weight (Weight, Body) 01/2023 - 01/2020
3	Inflammation (Inflammations) 12/2017 - 01/2014
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023 - 01/2018
2	Stroke (Strokes) 01/2023 - 01/2023
2	Heart Failure 01/2023 - 01/2023
2	Myocardial Infarction 01/2023 - 01/2023
2	Weight Loss (Weight Reduction) 01/2022 - 01/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2023
1	Chronic Renal Insufficiency 10/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Bone Fractures (Bone Fracture) 01/2023
1	Hypoglycemia (Reactive Hypoglycemia) 01/2023
1	Kidney Diseases (Kidney Disease) 01/2023
1	Hypertension (High Blood Pressure) 11/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2021
1	Weight Gain 10/2019
1	Birth Weight (Birth Weights) 10/2019
1	Metabolic Diseases (Metabolic Disease) 01/2018
1	Hyperinsulinism (Hyperinsulinemia) 11/2016
1	Albuminuria 03/2016
1	Hypotension (Low Blood Pressure) 03/2016
1	Diabetes Complications 10/2015
1	Disease Progression 02/2015
1	Hyperlipidemias (Hyperlipidemia) 01/2014
1	Hyperglycemia 01/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2008

Drug/Important Bio-Agent (IBA)

40	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 04/2009
24	Insulin (Novolin)FDA Link 10/2023 - 09/2009
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2016
4	LipidsIBA 01/2018 - 10/2013
3	SodiumIBA 01/2023 - 01/2023
3	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 01/2021
3	dapagliflozinIBA 01/2023 - 01/2021
3	Liraglutide FDA Link 01/2022 - 01/2019
3	Glucagon (Glukagon)FDA Link 01/2021 - 11/2016
3	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2019 - 07/2015
3	CholesterolIBA 06/2014 - 03/2008
2	empagliflozinIBA 01/2023 - 01/2023
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 03/2016
2	CarbohydratesIBA 01/2020 - 08/2017
2	Blood Glucose (Blood Sugar)IBA 10/2019 - 01/2018
2	AdiponectinIBA 12/2017 - 11/2016
2	C-Reactive ProteinIBA 11/2016 - 10/2013
1	InsulinsIBA 10/2023
1	insulin degludecIBA 10/2023
1	Insulin Glargine (Lantus)FDA Link 10/2023
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	oxidized low density lipoproteinIBA 11/2022
1	SugarsIBA 01/2022
1	Sodium-Glucose Transport ProteinsIBA 01/2022
1	Retinaldehyde (Retinal)IBA 05/2021
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 11/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2020
1	C-PeptideIBA 10/2019
1	LDL CholesterolIBA 10/2019
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2019
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Amino Acids FDA Link 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	Alanine (L-Alanine)FDA Link 01/2018
1	A 7 (A-7)IBA 01/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2017
1	Immunoglobulin M (IgM)IBA 11/2017
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2016
1	Interleukin-6 (Interleukin 6)IBA 11/2016
1	lipoprotein cholesterolIBA 03/2016
1	Pyruvaldehyde (Methylglyoxal)IBA 10/2015
1	CytokinesIBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 10/2013
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 09/2009

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2020
4	Injections 01/2022 - 01/2018
2	Glycemic Control 01/2023 - 01/2022
1	Precision Medicine 12/2023
1	Surgical Amputation (Amputations) 01/2023